ID NOW™
MOLECULAR SYSTEM
HELPS YOU EMPOWER YOUR CLINICIANS TO DIFFERENTIATE AT THE POINT OF ACCESS
This winter, differentiating between the symptoms of respiratory infections at acute care is even more challenging.1-3
IT IS A CONNECTABLE, EASY-TO-USE INSTRUMENT, PROVIDING POSITIVE RESULTS FOR:
• Influenza A & B in as little as 5 minutes, with 95% detected within 7 minutes4 in 13 minutes5
• RSV in 13 minutes or less5
• Strep A in as little as 2 minutes, with 99% detected within 3 minutes6
• SARS-CoV-2 in 13 minutes or less
SCAN TO LEARN MORE ABOUT ID NOW™
and negative results in 6 minutes5 and negative results
1. NHS England and NHS Improvement. Primary Care Bulletin. Updated June 29, 2021. Accessed November 2021.
https://www.england.nhs.uk/coronavirus/ primary-care/other-resources/primarycarebulleting/june-2021. 2. Zhou H, Tsou JH, Chinthalapally M, Liu H, Jiang F. Detection and Differentiation of SARS-CoV-2, Influenza, and Respiratory Syncytial Viruses by CRISPR. Diagnostics. 2021;11(5):823. 3. MedTech Europe. The Value of Diagnostic Information in Acute Respiratory Infections — Observations From the COVID-19 Pandemic. Accessed November 2021.
https://www.medtecheurope.org/wp- content/uploads/2021/04/vodi-case-on-respiratory- disease_case-study.pdf. 4. Moore N, et al. Evaluation of the Alere™ i Influenza A & B 2 Assay. Poster presented at: ASM Clinical Virology Symposium; 2018; West Palm Beach, Florida. 5. Abbott. ID NOW™ Product Inserts. 6. Abbott. Data on File. ID NOW™ Strep A 2 Clinical Trial.
© 2021 Abbott. All rights reserved. All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners. Any photos displayed are for illustrative purposes only. Any person depicted in such photos is a model. COL-08640-01 11/21
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
